Eli Lilly Message Board - Msg: 33140860

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 820.10

-0.8%

Oct 28 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	1/12/2021 12:13:25 PM
	of 636

Eli Lilly CEO says Covid variant from South Africa may ‘evade’ its antibody drug Kevin Stankiewicz Eli Lilly CEO Dave Ricks told CNBC the company is not sure whether its Covid-19 antibody drugs will be effective against a coronavirus strain initially found in South Africa. However, he expressed confidence that the treatment would work on the variant found in the U.K. “The South African variant ... is the one of concern. It has more dramatic mutations to that spike protein, which is the target” of these antibody drugs, Ricks said on “Squawk Box.” “Theoretically, it could evade our medicines.” He said the company wants to work with the Food and Drug Administration on a plan to adapt antibody therapies to virus variants, including the one first discovered in South Africa. “We actually have a large library of these antibodies now that are sitting pre-clinically,” said Ricks. “We could think about a very expedited path to study them in maybe a month or two, and then authorize their use. That would seem to be a smart thing to do as this virus mutates.” o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next